Stocklund K E, Kessel M, Jensen R H
Chemotherapy. 1980;26(5):397-401. doi: 10.1159/000237932.
Following informed consent, 226 consecutive patients scheduled to undergo abdominal hysterectomy entered a randomized double-blind clinical trial to determine the efficacy of ornidazole versus placebo in the prevention of postoperative infections. Postoperative abscesses occurred in 2 patients (1.8%) in the ornidazole group compared to 5 patients (4.4% in the placebo group. Febrile episodes occurred in 6 patients (5.3% receiving ornidazole and in 13 patients (11.4%) receiving placebo.
在获得知情同意后,226例计划接受腹式子宫切除术的连续患者进入一项随机双盲临床试验,以确定奥硝唑与安慰剂在预防术后感染方面的疗效。奥硝唑组有2例患者(1.8%)发生术后脓肿,而安慰剂组有5例患者(4.4%)发生。接受奥硝唑治疗的6例患者(5.3%)出现发热,接受安慰剂治疗的13例患者(11.4%)出现发热。